Conatus Pharmaceuticals
About:
Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.
Website: http://www.conatuspharma.com
Top Investors: Advent Life Sciences, MPM Capital, Roche Venture Fund, Aberdare Ventures, Gilde Healthcare
Description:
Conatus Pharmaceuticals is a privately-held biotechnology company focused on the development of innovative human therapeutics to treat liver disease and cancer. Their lead program, CTS-1027, is currently undergoing Phase 2 clinical trials for the treatment of Hepatitis C Virus (HCV). Conatus licensed CTS-1027 from Hoffmann-La Roche in 2006, and to date its development has been the primary focus of the Company.
$62.1M
$1M to $10M
San Diego, California, United States
2005-01-01
info(AT)conatuspharma.com
Alfred P. Spada, Charles J. Cashion, Jennifer Cayer, Steven J. Mento
11-50
2013-06-12
Public
© 2025 bioDAO.ai